Gliquidone is a second generation sulfonylurea that selectively inhibits ATP-sensitive potassium channel currents (IKATP) in pancreatic ?-cells (IC50s = 0.45, 119.1, and 149.7 ?M for HIT-T15 cells, cardiomyocytes, and vascular smooth muscle cells, respectively). 1 It is also a peroxisome proliferator-activated receptor ? (PPAR?) agonist (EC50 = 10 ?M in a transactivation assay).
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Gliquidone (CAS 33342-05-1) industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Glequinone Tablets
Glequinone Sustained Release Tablets
Glequinone Capsule
Others
Market Segment by Product Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Finally, the report provides detailed profile and data information analysis of leading company.
Vanguard Pharma
Yiling Pharma
CR Double-Crane
TIPR
Jinheng Pharma
Dexa Medica
Boehringer Ingelheim
Menarini Belgium
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Gliquidone (CAS 33342-05-1) consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Gliquidone (CAS 33342-05-1) market by identifying its various subsegments.
3.Focuses on the key global Gliquidone (CAS 33342-05-1) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Gliquidone (CAS 33342-05-1) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Gliquidone (CAS 33342-05-1) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Gliquidone (CAS 33342-05-1) Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Gliquidone (CAS 33342-05-1) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Gliquidone (CAS 33342-05-1) Segment by Type
2.1.1 Glequinone Tablets
2.1.2 Glequinone Sustained Release Tablets
2.1.3 Glequinone Capsule
2.1.4 Others
2.2 Market Analysis by Application
2.2.1 Hospital Pharmacies
2.2.2 Retail Pharmacies
2.2.3 Online Pharmacies
2.3 Global Gliquidone (CAS 33342-05-1) Market Comparison by Regions (2017-2027)
2.3.1 Global Gliquidone (CAS 33342-05-1) Market Size (2017-2027)
2.3.2 North America Gliquidone (CAS 33342-05-1) Status and Prospect (2017-2027)
2.3.3 Europe Gliquidone (CAS 33342-05-1) Status and Prospect (2017-2027)
2.3.4 China Gliquidone (CAS 33342-05-1) Status and Prospect (2017-2027)
2.3.5 Japan Gliquidone (CAS 33342-05-1) Status and Prospect (2017-2027)
2.3.6 Southeast Asia Gliquidone (CAS 33342-05-1) Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Gliquidone (CAS 33342-05-1) Industry Impact
2.5.1 Gliquidone (CAS 33342-05-1) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Gliquidone (CAS 33342-05-1) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Gliquidone (CAS 33342-05-1) Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Gliquidone (CAS 33342-05-1) Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Gliquidone (CAS 33342-05-1) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Gliquidone (CAS 33342-05-1) Manufacturer Market Share
3.5 Top 10 Gliquidone (CAS 33342-05-1) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Gliquidone (CAS 33342-05-1) Market
3.7 Key Manufacturers Gliquidone (CAS 33342-05-1) Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Gliquidone (CAS 33342-05-1) Industry Key Manufacturers
4.1 Vanguard Pharma
4.1.1 Compan Detail
4.1.2 Vanguard Pharma Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification
4.1.3 Vanguard Pharma 132 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Vanguard Pharma News
4.2 Yiling Pharma
4.2.1 Compan Detail
4.2.2 Yiling Pharma Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification
4.2.3 Yiling Pharma Gliquidone (CAS 33342-05-1) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Vanguard Pharma News
4.3 CR Double-Crane
4.3.1 Compan Detail
4.3.2 CR Double-Crane Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification
4.3.3 CR Double-Crane Gliquidone (CAS 33342-05-1) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 CR Double-Crane News
4.4 TIPR
4.4.1 Compan Detail
4.4.2 TIPR Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification
4.4.3 TIPR Gliquidone (CAS 33342-05-1) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 TIPR News
4.5 Jinheng Pharma
4.5.1 Compan Detail
4.5.2 TIPR Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification
4.5.3 Jinheng Pharma Gliquidone (CAS 33342-05-1) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Jinheng Pharma News
4.6 Dexa Medica
4.6.1 Compan Detail
4.6.2 Dexa Medica Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification
4.6.3 Dexa Medica Gliquidone (CAS 33342-05-1) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Dexa Medica News
4.7 Boehringer Ingelheim
4.7.1 Compan Detail
4.7.2 Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification
4.7.3 Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Menarini Belgium
4.8.1 Compan Detail
4.8.2 Menarini Belgium Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification
4.8.3 Menarini Belgium Gliquidone (CAS 33342-05-1) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Menarini Belgium News
5 Global Gliquidone (CAS 33342-05-1) Market Segment by Big Type
5.1 Global Gliquidone (CAS 33342-05-1) Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Gliquidone (CAS 33342-05-1) Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Gliquidone (CAS 33342-05-1) Revenue and Market Share by Big Type (2017-2022)
5.2 Glequinone Tablets Sales Growth Rate and Price
5.2.1 Global Glequinone Tablets Sales Growth Rate (2017-2022)
5.2.2 Global Glequinone Tablets Price (2017-2022)
5.3 Glequinone Sustained Release Tablets Sales Growth Rate and Price
5.3.1 Global Glequinone Sustained Release Tablets Sales Growth Rate (2017-2022)
5.3.2 Global Glequinone Sustained Release Tablets Price (2017-2022)
5.4 Glequinone Capsule Sales Growth Rate and Price
5.4.1 Global Glequinone Capsule Sales Growth Rate (2017-2022)
5.4.2 Global Glequinone Capsule Price (2017-2022)
5.5 Others Sales Growth Rate and Price
5.5.1 Global Others Sales Growth Rate (2017-2022)
5.5.2 Global Others Price (2017-2022)
6 Global Gliquidone (CAS 33342-05-1) Market Segment by Big Application
6.1 Global Gliquidone (CAS 33342-05-1) Sales Market Share by Big Application (2017-2022)
6.2 Hospital Pharmacies Sales Growth Rate (2017-2022)
6.3 Retail Pharmacies Sales Growth Rate (2017-2022)
6.4 Online Pharmacies Sales Growth Rate (2017-2022)
7 Global Gliquidone (CAS 33342-05-1) Forecast
7.1 Global Gliquidone (CAS 33342-05-1) Revenue, Sales and Growth Rate (2022-2027)
7.2 Gliquidone (CAS 33342-05-1) Market Forecast by Regions (2022-2027)
7.2.1 North America Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
7.2.2 Europe Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
7.2.3 China Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
7.2.4 Japan Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
7.2.5 Southeast Asia Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
7.2.6 Other Regions Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
7.3 Gliquidone (CAS 33342-05-1) Market Forecast by Type (2022-2027)
7.3.1 Global Gliquidone (CAS 33342-05-1) Sales Forecast by Type (2022-2027)
7.3.2 Global Gliquidone (CAS 33342-05-1) Market Share Forecast by Type (2022-2027)
7.4 Gliquidone (CAS 33342-05-1) Market Forecast by Application (2022-2027)
7.4.1 Global Gliquidone (CAS 33342-05-1) Sales Forecast by Application (2022-2027)
7.4.2 Global Gliquidone (CAS 33342-05-1) Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Gliquidone (CAS 33342-05-1) Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Gliquidone (CAS 33342-05-1) Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Gliquidone (CAS 33342-05-1)
Figure Market Concentration Ratio and Market Maturity Analysis of Gliquidone (CAS 33342-05-1)
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Gliquidone (CAS 33342-05-1) Market Size by Big Type
Figure Global Market Share of Gliquidone (CAS 33342-05-1) by Big Type in 2021
Figure Glequinone Tablets Picture (2017-2022)
Figure Glequinone Sustained Release Tablets Picture (2017-2022)
Figure Glequinone Capsule Picture (2017-2022)
Global Gliquidone (CAS 33342-05-1) Market Size by Big Application
Table Global Gliquidone (CAS 33342-05-1) Market Size by Application
Figure Global Gliquidone (CAS 33342-05-1) Market Share by Big Application in 2021
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Gliquidone (CAS 33342-05-1) Comparison by Regions (M USD) (2017-2027)
Figure Global Gliquidone (CAS 33342-05-1) Market Size (Million US$) (2017-2027)
Figure North America Gliquidone (CAS 33342-05-1) Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Gliquidone (CAS 33342-05-1) Revenue (Million US$) Growth Rate (2017-2027)
Figure China Gliquidone (CAS 33342-05-1) Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Gliquidone (CAS 33342-05-1) Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Gliquidone (CAS 33342-05-1) Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Gliquidone (CAS 33342-05-1) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Gliquidone (CAS 33342-05-1) Sales by Manufacturer (2017-2022)
Figure Global Gliquidone (CAS 33342-05-1) Sales Market Share by Manufacturer in 2021
Table Global Gliquidone (CAS 33342-05-1) Revenue by Manufacturer (2017-2022)
Figure Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Manufacturer in 2021
Table Global Gliquidone (CAS 33342-05-1) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Gliquidone (CAS 33342-05-1) Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Gliquidone (CAS 33342-05-1) Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Gliquidone (CAS 33342-05-1) Market
Table Key Manufacturers Gliquidone (CAS 33342-05-1) Product Type
Table Mergers & Acquisitions Planning
Table Vanguard Pharma Company Profile
Table Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification of Vanguard Pharma
Table Gliquidone (CAS 33342-05-1) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Yiling Pharma Company Profile
Table Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification of Yiling Pharma
Table Gliquidone (CAS 33342-05-1) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Yiling Pharma Recent Development
Table CR Double-Crane Company Profile
Table Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification of CR Double-Crane
Table Gliquidone (CAS 33342-05-1) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table CR Double-Crane Main Business
Table CR Double-Crane Recent Development
Table TIPR Company Profile
Table Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification of TIPR
Table Gliquidone (CAS 33342-05-1) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table TIPR Main Business
Table TIPR Recent Development
Table TIPR Main Business
Table TIPR Recent Development
Table Jinheng Pharma Company Profile
Table Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification of Jinheng Pharma
Table Gliquidone (CAS 33342-05-1) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Jinheng Pharma Main Business
Table Jinheng Pharma Recent Development
Table Dexa Medica Company Profile
Table Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification of Dexa Medica
Table Gliquidone (CAS 33342-05-1) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dexa Medica Main Business
Table Dexa Medica Recent Development
Table Boehringer Ingelheim Company Profile
Table Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification of Boehringer Ingelheim
Table Gliquidone (CAS 33342-05-1) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table Menarini Belgium Company Profile
Table Gliquidone (CAS 33342-05-1) Product Introduction, Application and Specification of Menarini Belgium
Table Gliquidone (CAS 33342-05-1) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Menarini Belgium Main Business
Table Menarini Belgium Recent Development
Figure Global Gliquidone (CAS 33342-05-1) Sales and Growth Rate (2017-2022)
Figure Global Gliquidone (CAS 33342-05-1) Revenue and Growth Rate (2017-2022)
Table Global Gliquidone (CAS 33342-05-1) Sales by Regions (2017-2022)
Figure Global Gliquidone (CAS 33342-05-1) Sales Market Share by Regions in 2021
Table Global Gliquidone (CAS 33342-05-1) Revenue by Regions (2017-2022)
Figure Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Regions in 2021
Figure North America Gliquidone (CAS 33342-05-1) Sales and Growth Rate (2017-2022)
Figure Europe Gliquidone (CAS 33342-05-1) Sales and Growth Rate (2017-2022)
Figure China Gliquidone (CAS 33342-05-1) Sales and Growth Rate (2017-2022)
Figure Japan Gliquidone (CAS 33342-05-1) Sales and Growth Rate (2017-2022)
Figure Southeast Asia Gliquidone (CAS 33342-05-1) Sales and Growth Rate (2017-2022)
Figure Other Regions Gliquidone (CAS 33342-05-1) Sales and Growth Rate (2017-2022)
Table Global Gliquidone (CAS 33342-05-1) Sales by Big Type (2017-2022)
Table Global Gliquidone (CAS 33342-05-1) Sales Market Share by Big Type (2017-2022)
Figure Global Gliquidone (CAS 33342-05-1) Sales Market Share by Big Type in 2019
Table Global Gliquidone (CAS 33342-05-1) Revenue by Big Type (2017-2022)
Table Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Big Type (2017-2022)
Table Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Big Type in 2019
Figure Global Glequinone Tablets Sales Growth Rate (2017-2022)
Figure Global Glequinone Tablets Price (2017-2022)
Figure Global Glequinone Sustained Release Tablets Sales Growth Rate (2017-2022)
Figure Global Glequinone Sustained Release Tablets Price (2017-2022)
Figure Global Glequinone Capsule Sales Growth Rate (2017-2022)
Figure Global Glequinone Capsule Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global Gliquidone (CAS 33342-05-1) Sales by Big Application (2017-2022)
Table Global Gliquidone (CAS 33342-05-1) Sales Market Share by Big Application (2017-2022)
Figure Global Gliquidone (CAS 33342-05-1) Sales Market Share by Big Application in 2019
Figure Global Hospital Pharmacies Sales Growth Rate (2017-2022)
Figure Global Retail Pharmacies Sales Growth Rate (2017-2022)
Figure Global Online Pharmacies Sales Growth Rate (2017-2022)
Figure Global Gliquidone (CAS 33342-05-1) Sales and Growth Rate (2022-2027)
Figure Global Gliquidone (CAS 33342-05-1) Revenue and Growth Rate (2022-2027)
Table Global Gliquidone (CAS 33342-05-1) Sales Forecast by Regions (2022-2027)
Table Global Gliquidone (CAS 33342-05-1) Market Share Forecast by Regions (2022-2027)
Figure North America Sales Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
Figure Europe Sales Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
Figure China Sales Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
Figure Japan Sales Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
Figure Southeast Asia Sales Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
Figure Other Regions Sales Gliquidone (CAS 33342-05-1) Market Forecast (2022-2027)
Table Global Gliquidone (CAS 33342-05-1) Sales Forecast by Type (2022-2027)
Table Global Gliquidone (CAS 33342-05-1) Market Share Forecast by Type (2022-2027)
Table Global Gliquidone (CAS 33342-05-1) Sales Forecast by Application (2022-2027)
Table Global Gliquidone (CAS 33342-05-1) Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gliquidone (CAS 33342-05-1)
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Gliquidone (CAS 33342-05-1) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Gliquidone (CAS 33342-05-1) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Gliquidone (CAS 33342-05-1) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Gliquidone (CAS 33342-05-1) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Gliquidone (CAS 33342-05-1) Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Gliquidone (CAS 33342-05-1) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Gliquidone (CAS 33342-05-1) Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Gliquidone (CAS 33342-05-1) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Vanguard Pharma
Yiling Pharma
CR Double-Crane
TIPR
Jinheng Pharma
Dexa Medica
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)